Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.

BACKGROUND: Use of pneumococcal conjugate vaccines (PCVs) in resource-poor countries has focused on early infant immunisation with little emphasis on protection in late infancy and beyond. Boosting of the immune response later in infancy might provide improved persistence of immunogenicity into earl...

Full description

Bibliographic Details
Main Authors:	Hamaluba, M, Kandasamy, R, Upreti, S, Subedi, G, Shrestha, S, Bhattarai, S, Gurung, M, Pradhan, R, Voysey, M, Gurung, S, Pradhan, S, Thapa, A, Maharjan, R, Kiran, U, Kerridge, S, Hinds, J, van der Klis, F, Snape, M, Murdoch, D, Kelly, S, Kelly, D, Adhikari, N, Thorson, S, Pollard, A
Format:	Journal article
Language:	English
Published:	Elsevier 2015

Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.

Similar Items